The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Prevention of Acute Exacerbations of COPD
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–257 of 257
Román, M., Larraz, C., Gómez, A., Ripoll, J., Mir, I., Miranda, E. Z., Macho, A., Thomás, V., & Esteva, M. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-21 · Cited by 80
Appleton, S., Jones, T. E., Poole, P., Lasserson, T. J., Adams, R., Smith, B. J., & Muhammed, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006101 · Cited by 79
New Therapies for Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2010) · Medical Principles and Practice · doi:10.1159/000316368 · Cited by 78
Lainščak, M., Kadivec, S., Košnik, M., Benedik, B., Bratkovic, M., Jakhel, T., Marčun, R., Miklosa, P., Stalc, B., & Farkaš, J. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.003 · Cited by 76
Walters, J. A., Smith, S., Poole, P., Granger, R. H., & Wood-Baker, R. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub3 · Cited by 76
Chemoprevention of Lung Cancer
Szabo, E. M., Mao, J. T., Lam, S. C., Reid, M. E., & Keith, R. L. (2013) · CHEST Journal · doi:10.1378/chest.12-2348 · Cited by 74
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis
Schermer, T. R., Chavannes, N. H., Dekhuijzen, R. P. N., Wouters, E. F. �., Muris, J. W. M., Akkermans, R. L. C., van Schayck, O. C. P., & van Weel, C. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.003 · Cited by 73
Allegra, L., Cordaro, C. I., & Grassi, C. (2009) · Respiration · doi:10.1159/000196540 · Cited by 72
Lewis, K. E., Annandale, J. A., Warm, D. L., Rees, S. E., Hurlin, C., Blyth, H., Syed, Y., & Lewis, L. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903499555 · Cited by 70
Sin, D. D., Jen, & Rennard, S. I. (2012) · International Journal of COPD · doi:10.2147/copd.s32765 · Cited by 69
Statins and outcome after hospitalization for COPD exacerbation: A prospective study
Bartziokas, Κ., Papaioannou, A. Ι., Minas, M., Κostikas, Κ., BANYA, W. A. S., Daniil, Z. D., Haniotou, A., & Gourgoulianis, K. I. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.06.003 · Cited by 68
Ringbæk, T., Brøndum, E., Martinez, G., Thøgersen, J., & Lange, P. (2010) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e3181c9c985 · Cited by 68
Inhaled Corticosteroids vs Placebo for Preventing COPD Exacerbations
Agarwal, R., Aggarwal, A. N., Gupta, D., et al. (2009) · CHEST Journal · doi:10.1378/chest.09-1305 · Cited by 68
Oral fabrol (oral N-acetylcysteine) in chronic bronchitis
Parr, G., & Huitson, A. (1987) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(87)90182-3 · Cited by 65
Campbell, S. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.156 · Cited by 62
Sánchez, F. J., Ruiz, F. Ó., Parra, C. L., Gómez‐Suárez, C., Jordán, A., Pérez, P., Bonachela, P., Leal, S., & Barrot, E. (2013) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x12473909 · Cited by 62
24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD
van Noord, J. A., Smeets, J. J., Drenth, B. M., Rascher, J., Pivovarova, A., Hamilton, A., & Cornelissen, P. J. G. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.07.006 · Cited by 60
Bogaert, D., van der Valk, P., Ramdin, R., Sluijter, M., Monninkhof, E. M., Hendrix, R., de Groot, R., & Hermans, P. W. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.818-823.2004 · Cited by 59
Smith, B. J., Appleton, S., Bennett, P. W., Roberts, G. C., Fante, P. D., Adam, R., Trott, C. M., Allan, D. P., Southcott, A. M., & Ruffin, R. E. (1999) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1999.tb01621.x · Cited by 58
Ställberg, B., Selroos, O., Vogelmeier, C. F., Andersson, E. K. M., Ekström, T., & Larsson, K. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-11 · Cited by 56
Halpin, D. M. G., Laing-Morton, T., Spedding, S., Levy, M. L., Coyle, P. V., Lewis, J., Newbold, P., & Marno, P. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00057 · Cited by 56
Cost-Utility Analysis of a Telerehabilitation Program: A Case Study of COPD Patients
Hæsum, L. K. E., Sørensen, N., Dinesen, B., Nielsen, C., Grann, O., Hejlesen, O. K., Toft, E. S., & Ehlers, L. H. (2012) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2011.0250 · Cited by 56
N-acetylcysteine by metered dose inhaler in thetreatment of chronic bronchitis: a multi-centre study
Dueholm, M., Nielsen, C., Thorshauge, H., Evald, T., Hansen, N.-C., Madsen, H., & Maltb˦k, N. (1992) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80220-9 · Cited by 55
Huang, C., Chan, W., Chen, Y., Chen, T., Chou, K., Lin, S., Chen, J., & Leu, H. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.08.010 · Cited by 54
WOOD‐BAKER, R., McGLONE, S., VENN, A., & WALTERS, E. H. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00902.x · Cited by 53
Wakabayashi, R., Motegi, T., Yamada, K., Ishii, T., Jones, R. C. M., Hyland, M. E., Gemma, A., & Kida, K. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00696.x · Cited by 51
Borglykke, A., Pisinger, C. H., Jørgensen, T., & Ibsen, H. (2008) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2008.00055.x · Cited by 49
Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease
Miravitlles, M., García-Polo, C., Doménech, A., Villegas, G., Conget, F., & de la Roza, C. (2013) · Lung · doi:10.1007/s00408-013-9487-z · Cited by 49
Braga, P. C., Allegra, L., Rampoldi, C., Ornaghi, A., & Beghi, G. (2009) · Respiration · doi:10.1159/000195871 · Cited by 48
Venter, A., Burns, R. A., Hefford, M., & Ehrenberg, N. (2012) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2012.sft112 · Cited by 47
Soler‐Cataluña, J. J., Martínez‐García, M. Á., Román, P., Orero, R., Terrazas, S., & Martínez-Pechuán, A. (2006) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(06)60576-4 · Cited by 47
Rodrigo, G. J., Plaza, V., & Castro-Rodríguez, J. A. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.10.006 · Cited by 46
Paré, G., Poba‐Nzaou, P., Sicotte, C., Beaupré, A., Lefrançois, É., Nault, D., & Saint-Jules, D. (2013) · European Research in Telemedicine / La Recherche Européenne en Télémédecine · doi:10.1016/j.eurtel.2013.05.001 · Cited by 45
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients
Gross, N. J., Nelson, H. S., Lapidus, R. J., Dunn, L., Lynn, L., Rinehart, M., & Denis-Mize, K. S. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.007 · Cited by 45
de Miguel‐Díez, J., Carrasco‐Garrido, P., Rejas, J., Centeno, A. M., Gobartt, E., Hernández‐Barrera, V., de Miguel, Á. G., & Jiménez‐García, R. (2011) · Lung · doi:10.1007/s00408-011-9289-0 · Cited by 44
Cost-effectiveness of an Intensive Smoking Cessation Intervention for COPD Outpatients
Christenhusz, L. C. A., Prenger, R., Pieterse, M. E., Seydel, E. R., & van der Palen, J. A. M. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr263 · Cited by 44
Kelleher, D. L., Mehta, R. S., Jean-Francois, B., Preece, A., Blowers, J., Crater, G., & Thomas, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050716 · Cited by 43
Roflumilast in Asian patients with COPD: A randomized placebo‐controlled trial
LEE, S., Hui, D. S. C., Mahayiddin, A. A., Roa, C. C., Kwa, K. H., Goehring, U.-M., Bredenbröker, D., & Kuo, H. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02038.x · Cited by 42
Development of New Drugs for COPD
Barnes, P. J. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320120005 · Cited by 40
Reducing the Frequency and Severity of Exacerbations of Chronic Obstructive Pulmonary Disease
Calverley, P. M. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306031 · Cited by 37
An update on bronchodilators in Phase I and II clinical trials
Cazzola, M., Rogliani, P., Segreti, A., & Matera, M. G. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.710602 · Cited by 36
Telehealth reduces hospital admission rates in patients with COPD
Holland, A. E. (2013) · Journal of physiotherapy · doi:10.1016/s1836-9553(13)70168-1 · Cited by 33
Pinnock, H., Hanley, J., Lewis, S. C., MacNee, W., Pagliari, C., Pol, M. M. V. D., Sheikhg, A., & McKinstry, B. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00040 · Cited by 32
Eficacia de un programa específico para pacientes con EPOC que presentan frecuentes agudizaciones
Soler‐Cataluña, J. J., Martínez‐García, M. Á., Román, P., Orero, R., Terrazas, S., & Martínez-Pechuán, A. (2006) · Archivos de Bronconeumología · doi:10.1157/13093392 · Cited by 32
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
Jones, P., Mahler, D. A., Gale, R., Owen, R. J., & Krämer, B. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.013 · Cited by 31
Results of a multicenter study of nebulized inhalant bronchodilator solutions
Tashkin, D. P., Bleecker, E. R., Braun, S. R., Campbell, S. C., DeGraff, A. C., Hudgel, D. W., Boyars, M. C., & Sahn, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80109-4 · Cited by 29
Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease
Colice, G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80037-4 · Cited by 27
Emerging drugs for chronic obstructive pulmonary disease
Matera, M. G., Calzetta, L., Segreti, A., & Cazzola, M. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.660917 · Cited by 26
Thabane, M. E. (2012) · Europe PMC (PubMed Central) · Cited by 26
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease
Karner, C., Chong, J., & Poole, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009157 · Cited by 25
Cazzola, M., Ciaprini, C., Page, C. P., & Matera, M. G. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1273 · Cited by 24
Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
Chung, V. C., Ma, H., Hui, D. S. C., Tam, W., & Tang, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070784 · Cited by 24
Grillage, M. G., & Barnard‐Jones, K. (1985) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1985.tb07868.x · Cited by 24
Home telecare study for patients with chronic lung disease in the Sydney West Area Health Service.
Shany, T., Hession, M., Pryce, D. H., Galang, R., Roberts, M., Lovell, N. H., & Basilakis, J. (2010) · PubMed · Cited by 21
Mak, G., & Hanania, N. A. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.019 · Cited by 21
Self-citationEffects of inhaled corticosteroids in stable chronic obstructive pulmonary disease
Glaab, T., & Taube, C. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.08.006 · Cited by 18
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
Kruis, A. L., Smidt, N., Assendelft, W. J., Gussekloo, J., Boland, M. R. S., Mölken, M. R., & Chavannes, N. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009437 · Cited by 15
Cited by
Rochester, C. L., Vogiatzis, I., Holland, A. E., Lareau, S. C., Marciniuk, D. D., Puhan, M. A., Spruit, M. A., Masefield, S., Casaburi, R., Clini, E. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-1966st · Cited by 856
Self-citationTowards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citationUpdate on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Celli, B. R., & Wedzicha, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900500 · Cited by 461
Self-citationCOPD Guidelines: A Review of the 2018 GOLD Report
Mirza, S., Clay, R. D., Koslow, M. A., & Scanlon, P. D. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.026 · Cited by 444
Ko, F. W., Chan, K. P., Hui, D. S., Goddard, J. R., Shaw, J. G., Reid, D. W., & Yang, I. A. (2016) · Respirology · doi:10.1111/resp.12780 · Cited by 354
Metadata
- Authors
- Criner, G. J., Bourbeau, J., Diekemper, R. L., Ouellette, D. R., Goodridge, D., Hernandez, P., Curren, K., Balter, M. S., Bhutani, M., Camp, P. G., Celli, B. R., Dechman, G., Dransfield, M. T., Fiel, S. B., Foreman, M. G., Hanania, N. A., Ireland, B. K., Marchetti, N., Marciniuk, D. D., Mularski, R. A., Ornelas, J., Road, J. D., & Stickland, M. K.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 147
- Issue
- 4
- Pages
- 894-942
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2064058982
- Cited by
- 288
- References
- 257
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.